https://www.foxotechnologies.com/ https://www.foxotechnologies.com/about https://www.foxotechnologies.com/about/management-team https://www.foxotechnologies.com/about/board-of-directors https://www.foxotechnologies.com/solutions https://www.foxotechnologies.com/investors https://www.foxotechnologies.com/investors/news-events/press-releases https://www.foxotechnologies.com/investors/news-events/ir-calendar https://www.foxotechnologies.com/investors/news-events/presentations https://www.foxotechnologies.com/investors/news-events/email-alerts https://www.foxotechnologies.com/investors/company-information https://www.foxotechnologies.com/investors/company-information/executive-team https://www.foxotechnologies.com/investors/company-information/contacts https://www.foxotechnologies.com/investors/company-information/faq https://www.foxotechnologies.com/investors/financial-information/financial-results https://www.foxotechnologies.com/investors/financial-information/income-statement https://www.foxotechnologies.com/investors/financial-information/balance-sheet https://www.foxotechnologies.com/investors/financial-information/cash-flow https://www.foxotechnologies.com/investors/stock-data/quote-chart https://www.foxotechnologies.com/investors/stock-data/historical-data https://www.foxotechnologies.com/investors/sec-filings/all-sec-filings https://www.foxotechnologies.com/investors/sec-filings/annual-reports https://www.foxotechnologies.com/investors/sec-filings/quarterly-reports https://www.foxotechnologies.com/investors/sec-filings/section-16-filings https://www.foxotechnologies.com/investors/corporate-governance/board-of-directors https://www.foxotechnologies.com/investors/corporate-governance/board-committees https://www.foxotechnologies.com/investors/corporate-governance/governance-documents https://www.foxotechnologies.com/contact https://www.foxotechnologies.com/investors/news-events/press-releases/detail/90/foxo-technologies-inc-s-subsidiary-vector-biosource-inc-enters-into-definitive-agreement-to-acquire-four-blood-collection-centers-from-grifols-bio-supplies-inc 2026-07-29T08:30:03-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/89/foxo-technologies-inc-ceo-seamus-lagan-provides-mid-year-update-to-shareholders 2026-07-06T09:07:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/88/foxo-technologies-inc-announces-completion-of-reverse-stock-split 2026-07-01T07:30:19-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/87/foxo-technologies-inc-forms-strategic-partnership-with-longevityfp-technologies-llc-to-commercialize-foxos-epigenetics-technology 2026-05-28T08:33:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/86/foxo-technologies-inc-subsidiary-big-south-fork-medical-center-expands-clinical-capabilities 2026-01-20T08:07:01-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/85/foxo-technologies-inc-ceo-seamus-lagan-provides-year-end-review-to-shareholders 2025-12-15T08:07:01-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/84/foxo-technologies-inc-subsidiary-myrtle-recovery-centers-recognized-by-the-rural-health-association-of-tennessee-for-outstanding-community-impact 2025-12-09T08:07:01-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/83/foxo-technologies-inc-announces-closing-of-vector-biosource-inc-acquisition 2025-09-22T08:17:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/82/foxo-technologies-inc-announces-acquisition-agreement-to-acquire-vector-biosource-inc 2025-09-11T07:42:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/81/foxo-technologies-inc-announces-that-its-common-stock-can-be-quoted-and-traded-on-the-over-the-counter-market-from-august-13-2025 2025-08-13T07:52:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/80/foxo-technologies-inc-announces-execution-of-a-non-binding-acquisition-agreement-for-an-assisted-living-facility-in-south-florida-for-a-total-consideration-of-22-million 2025-08-06T07:43:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/79/foxo-technologies-inc-s-big-south-fork-medical-center-completes-performance-network-agreement-with-covenant-health-to-provide-swing-bed-services 2025-08-01T07:52:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/78/foxo-technologies-inc-announces-license-renewal-and-provides-operational-update-for-myrtle-recovery-centers-inc 2025-07-31T07:23:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/77/foxo-technologies-inc-announces-intention-to-spin-off-epigenetics-subsidiary 2025-07-18T07:03:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/76/foxo-technologies-inc-announces-reverse-stock-split 2025-07-17T17:20:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/75/foxo-technologies-inc-s-behavioral-health-subsidiary-has-been-approved-to-receive-scott-county-opioid-abatement-funds 2025-06-30T07:22:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/74/foxo-technologies-inc-designates-new-series-of-preferred-stock-to-be-used-for-acquisitions 2025-06-27T07:27:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/73/foxo-technologies-inc-s-critical-access-hospital-announces-new-wound-care-services-offering 2025-06-17T08:07:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/72/foxo-technologies-inc-creates-acquisition-vehicle-and-appoints-new-interim-cfo 2025-06-16T07:43:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/71/foxo-technologies-inc-completes-equity-funding-agreement 2025-06-04T08:08:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/70/foxo-technologies-inc-s-critical-access-hospital-announces-expansion-of-services-to-include-wound-care 2025-05-19T08:05:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/69/foxo-technologies-inc-s-behavioral-health-subsidiary-reaches-key-operational-milestones 2025-05-06T08:05:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/68/foxo-technologies-inc-announces-completion-of-reverse-stock-split 2025-04-29T10:05:02-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/67/foxo-technologies-inc-announces-reverse-stock-split 2025-04-17T17:00:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/66/foxo-technologies-inc-announces-filing-of-its-annual-report-on-form-10-k 2025-04-16T17:45:01-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/65/foxo-technologies-inc-announces-execution-of-a-non-binding-agreement-to-acquire-vector-biosource-inc 2025-03-19T08:07:00-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/64/foxo-technologies-inc-provides-update-on-its-behavioral-health-subsidiary-myrtle-recovery-centers-inc 2025-03-12T08:10:00-04:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/63/foxo-technologies-inc-announces-execution-of-a-non-binding-acquisition-agreement-for-two-assisted-living-facilities-in-florida-for-a-total-consideration-of-60-million 2025-02-24T08:10:00-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/62/foxo-technologies-inc-provides-update-on-recent-acomplishments-and-business-strategy 2025-02-19T10:49:58-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/5/foxo-technologies-inc-confirms-details-of-special-meeting-of-shareholders-on-january-17-2025 2025-01-23T16:21:27-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/6/foxo-technologies-inc-s-board-of-directors-announces-special-meeting-of-shareholders 2025-01-23T16:21:27-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/7/foxo-technologies-inc-anounces-details-of-its-2024-annual-general-meeting-of-shareholders-to-be-held-on-december-31-2024 2025-01-23T16:21:27-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/8/foxo-technologies-inc-announces-that-stockholders-equity-is-greater-than-4m-which-is-required-to-meet-the-continued-listing-requirements-of-the-nyse-american-exchange 2025-01-23T16:21:27-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/9/foxo-technologies-inc-announces-restructuring-and-capital-raising-transactions-and-appoints-seamus-lagan-as-chief-executive-officer 2025-01-23T16:21:27-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/10/foxo-technologies-inc-announces-results-of-specialmeeting-of-shareholders 2025-01-23T16:21:28-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/11/foxo-technologies-inc-confirms-details-of-special-meeting-of-shareholders-on-november-29-2024 2025-01-23T16:21:28-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/12/foxo-technologies-inc-confirms-details-of-special-meeting-of-shareholders-on-december-29-2024 2025-01-23T16:21:28-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/13/foxo-technologies-inc-s-board-of-directors-announces-special-meeting-of-shareholders 2025-01-23T16:21:28-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/14/foxo-technologies-inc-provides-update-on-2024-accomplishments-and-plans-for-remainder-of-the-year 2025-01-23T16:21:28-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/15/foxo-technologies-inc-completes-the-acquisition-of-revenue-generating-operations-from-rennova-health-inc 2025-01-23T16:21:29-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/16/foxo-technologies-subsidiary-myrtle-recovery-centers-receives-two-full-licenses-from-the-tennessee-department-of-mental-health-and-substance-abuse-services 2025-01-23T16:21:29-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/17/foxo-technologies-inc-announces-receipt-of-notice-of-non-compliance-with-nyse-continued-listing-requirements 2025-01-23T16:21:29-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/18/foxo-technologies-inc-regains-compliance-with-sec-reporting-requirements 2025-01-23T16:21:29-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/19/foxo-technologies-inc-secures-up-to-2-8-million-in-senior-notes-to-fund-previously-announced-acquisition-of-myrtle-recovery-centers-inc-and-provide-additional-working-capital 2025-01-23T16:21:29-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/20/foxo-technologies-inc-announces-receipt-of-notice-of-non-compliance-with-nyse-continued-listing-requirements-completes-steps-it-believes-are-required-to-regain-compliance 2025-01-23T16:21:30-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/21/foxo-technologies-enters-into-share-exchange-agreements-to-acquire-healthcare-operations-from-rennova-health-inc 2025-01-23T16:21:30-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/22/foxo-technologies-inc-announces-receipt-of-notice-of-non-compliance-with-nyse-continued-listing-requirements 2025-01-23T16:21:30-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/23/foxo-technologies-announces-non-binding-agreement-for-potentially-transformative-merger-with-m2i-global 2025-01-23T16:21:30-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/24/foxo-technologies-announces-appointment-of-capital-markets-veteran-francis-colt-dewolf-to-the-board-of-directors 2025-01-23T16:21:30-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/25/foxo-technologies-formalizes-license-agreement-with-kr8-ai-to-power-new-epigenetic-wellness-solutions 2025-01-23T16:21:30-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/26/foxo-technologies-inc-announces-receipt-of-notice-of-non-compliance-with-nyse-continued-listing-requirements 2025-02-19T10:49:47-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/27/foxo-technologies-on-track-to-commence-commercial-rollout-of-vithar-ai-health-coach-in-early-2024 2025-01-23T16:21:30-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/28/foxo-technologies-receives-notice-from-nyse-american-regarding-late-filing-of-quarterly-report-on-form-10-q 2025-01-23T16:21:31-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/29/foxo-technologies-provides-reminder-for-webinar-to-be-held-today-november-10th-at-10-am-eastern-time-to-unveil-vithar-ai-health-coach 2025-01-23T16:21:31-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/30/foxo-technologies-to-unveil-vithar-ai-health-coach-schedules-webinar-for-friday-november-10th-at-10-am-eastern-time 2025-01-23T16:21:31-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/31/foxo-technologies-expects-class-a-common-stock-to-resume-trading-today-november-7-in-connection-with-1-for-10-reverse-stock-split 2025-01-23T16:21:31-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/32/foxo-technologies-unveils-plans-for-new-direct-to-consumer-offering-combining-the-companys-epigenetic-data-with-the-power-of-ai 2025-01-23T16:21:31-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/33/foxo-technologies-inc-announces-reverse-stock-split 2025-01-23T16:21:31-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/34/foxo-technologies-completes-strategic-alternatives-review-and-outlines-latest-progress-executing-corporate-strategy 2025-01-23T16:21:31-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/35/foxo-technologies-announces-issue-notification-from-uspto-for-a-patent-leveraging-machine-learning-approaches-to-enable-the-commercialization-of-epigenetic-biomarkers 2025-01-23T16:21:31-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/36/foxo-technologies-interim-ceo-mark-white-provides-letter-to-shareholders-outlining-new-ai-enabled-direct-to-consumer-strategy-and-immediate-expense-reductions 2025-01-23T16:21:31-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/37/foxo-technologies-announces-agreement-with-atrio-insurance 2025-01-23T16:21:31-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/38/foxo-technologies-inc-announces-nyse-american-acceptance-of-compliance-plan 2025-01-23T16:21:32-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/39/foxo-technologies-inc-announces-receipt-of-second-notice-of-non-compliance-from-nyse-american 2025-01-23T16:21:32-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/40/foxo-technologies-collaborates-with-datarobot-to-pave-the-way-for-ai-driven-epigenetic-biomarker-research-in-human-longevity 2025-01-23T16:21:32-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/41/foxo-technologies-announces-second-quarter-2023-financial-results 2025-01-23T16:21:34-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/42/foxo-technologies-sets-second-quarter-2023-business-update-call-for-thursday-august-10-2023-at-3-15-p-m-ct 2025-01-23T16:21:35-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/43/longevity-biotech-companies-gero-and-foxo-technologies-to-embark-on-joint-initiative-on-artificial-intelligence-and-epigenetic-data-to-discover-signatures-of-human-health-trajectories 2025-01-23T16:21:35-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/44/foxo-technologies-launches-bioinformatics-services-to-revolutionize-epigenetic-data-analysis 2025-01-23T16:21:35-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/45/foxo-technologies-inc-announces-receipt-of-notice-of-non-compliance-with-nyse-continued-listing-requirements 2025-01-23T16:21:35-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/46/foxo-technologies-announces-results-of-annual-stockholders-meeting 2025-01-23T16:21:35-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/47/nyse-american-has-commenced-delisting-proceedings-in-the-foxo-ws-warrants-of-foxo-technologies-inc 2025-01-23T16:21:35-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/48/foxo-technologies-announces-first-quarter-2023-financial-results 2025-01-23T16:21:36-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/50/foxo-technologies-announces-direct-to-consumer-launch-of-longevity-report-beta-product 2025-01-23T16:21:36-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/49/foxo-technologies-announces-resignation-of-taylor-fay-chief-operating-officer 2025-01-23T16:21:36-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/51/foxo-technologies-announces-full-year-2022-financial-results-and-recent-business-highlights 2025-01-23T16:21:38-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/52/foxo-technologies-inc-sets-fourth-quarter-and-full-year-2022-business-update-call-for-thursday-march-30-2023-at-3-15-p-m-ct 2025-01-23T16:21:38-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/53/foxo-life-to-begin-distribution-relationship-with-amsuisse-to-sell-life-insurance-designed-to-keep-you-alive 2025-01-23T16:21:38-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/54/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022 2025-01-23T16:21:41-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/55/foxo-technologies-announces-management-changes-and-delays-filing-of-form-10-q 2025-01-23T16:21:42-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/56/foxo-technologies-announces-departure-of-chief-product-officer-erin-sharoni 2025-01-23T16:21:42-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/57/foxo-technologies-postpones-third-quarter-2022-earnings-report-and-conference-call 2025-01-23T16:21:42-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/58/foxo-technologies-announces-agreement-with-haven-life 2025-01-23T16:21:42-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/59/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-3-15-p-m-ct 2025-01-23T16:21:42-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/60/foxo-technologies-announces-first-distribution-partner-and-begins-product-rollout-in-california-expands-executive-team-with-insurance-industry-talent 2025-01-23T16:21:42-05:00 https://www.foxotechnologies.com/investors/news-events/press-releases/detail/61/longevity-science-leader-foxo-technologies-inc-to-list-on-nyse-american-following-successful-business-combination-with-delwinds-insurance-acquisition-corp 2025-01-23T16:21:43-05:00 https://www.foxotechnologies.com/investors/sec-filings/all-sec-filings/content/0001493152-26-038352/formpre14c.htm 2026-08-14T16:47:40-04:00 https://www.foxotechnologies.com/investors/sec-filings/all-sec-filings/content/0001493152-26-038401/form10-q.htm 2026-08-14T16:34:39-04:00 https://www.foxotechnologies.com/investors/sec-filings/all-sec-filings/content/0001493152-26-038356/form8-k.htm 2026-08-14T16:23:59-04:00 https://www.foxotechnologies.com/investors/sec-filings/all-sec-filings/content/0001493152-26-035110/form8-k.htm 2026-07-29T08:35:53-04:00 https://www.foxotechnologies.com/investors/sec-filings/all-sec-filings/content/0001493152-26-034793/form8-k.htm 2026-07-27T16:07:32-04:00 https://www.foxotechnologies.com/investors/sec-filings/all-sec-filings/content/0001493152-26-032156/form8-k.htm 2026-07-06T16:06:26-04:00 https://www.foxotechnologies.com/investors/sec-filings/all-sec-filings/content/0001493152-26-031543/form8-k.htm 2026-07-01T16:06:15-04:00 https://www.foxotechnologies.com/investors/sec-filings/all-sec-filings/content/0001493152-26-026842/formdef14c.htm 2026-06-03T09:52:59-04:00 https://www.foxotechnologies.com/investors/sec-filings/all-sec-filings/content/0001493152-26-025636/form8-k.htm 2026-05-28T16:46:52-04:00 https://www.foxotechnologies.com/privacy-policy https://www.foxotechnologies.com/disclaimer https://www.foxotechnologies.com/sitemap https://www.foxotechnologies.com/accessibility-statement